Trial Finds Patients Receiving CroFab® Antivenom Less Likely to Use Opioids for Pain Control - Finger Lakes Times

Trial Finds Patients Receiving CroFab® Antivenom Less Likely to Use Opioids for Pain Control  Finger Lakes Times

PHILADELPHIA--(BUSINESS WIRE)--Apr 29, 2019--BTG plc (LSE: BTG), the global healthcare company, today announced the publication of a trial, "Antivenom ...